pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$SGIOFSHIONOGI & CO LTD

$SGIOF17.90+2.58%
Osaka, JPupdated 13h ago

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 3
  • tagPain1 co-mentions · 1 sources
  • drugdaridorexant hydrochloride1 co-mentions · 1 sources
  • drugJTE-0511 co-mentions · 1 sources
pipeline
13
marketed
5
phase 3
1
catalysts ytd
6
approvals ytd
0
recalls ytd
0

Pipeline(13)

view full pipeline →
pipeline depth13 products
Phase 1: 1Phase 2: 4Phase 3: 1Marketed: 5pre_registration: 1Unknown: 1
1Phase 14Phase 21Phase 35Marketed1pre_registration1Unknown
Marketed
Radicava
Amyotrophic Lateral Sclerosis
Marketed
baloxavir marboxil
Unspecified Influenza Virus Infections
Polymerase acidic protein
Marketed
cefiderocol sulfate tosylate
Hospital Acquired Pneumonia (HAP)
Bacterial penicillin-binding protein
Marketed
edaravone
Amyotrophic Lateral Sclerosis
Marketed
lusutrombopag
Thrombocytopenia
Phase 3
zatolmilast
Fragile X Syndrome
3',5'-cyclic-AMP phosphodiesterase 4D
Phase 2
S-309309
Obesity
Phase 2
S-337395
Respiratory Syncytial Virus (RSV) Infections
Phase 2
S-531011
Adenocarcinoma Of The Gastroesophageal Junction
Phase 2
secutrelvir
Coronavirus Disease 2019 (COVID-19)
Phase 1
S-740792
Gait Abnormality (Walking Difficulty)
drug
JTE-051

📅 Upcoming

Oct 29, 2026
earnings
$SGIOF17.90+2.58%
in 3mo
SHIONOGI & CO LTD earnings
SHIONOGI & CO LTD
→

🕒 Recent(90d)

earnings (2)
Aug 3, 2026
earnings
$SGIOF17.90+2.58%
8d ago
SHIONOGI & CO LTD earnings
SHIONOGI & CO LTD
→
Jul 30, 2026
earnings
$SGIOF17.90+2.58%
12d ago
SHIONOGI & CO LTD earnings
SHIONOGI & CO LTD
→
view all catalysts →
🐶 Hiring Signal
next earnings Oct 29, 2026
No open roles indexed yet — view SHIONOGI & CO LTD jobs →

News

no news has mentioned this company yet
identifiers
ticker
$SGIOF
SEC CIK
0001281721
country
JP
source
sec_tickers
top tags
Infectious Disease5ALS1Alzheimer's Disease1Melanoma1NSCLC1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 6m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?